Tech Company Inital Public Offerings
Alimera Sciences IPO
Headquartered in Alpharetta, Alimera Sciences is now a public company.
Transaction Overview
Company Name
Announced On
4/22/2010
Transaction Type
IPO
Amount
$72,000,000
Proceeds Purpose
Proceeds purposes are detailed in the company statements on file with the SEC.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
6120 Windward Pkwy. 290
Alpharetta, GA 30005
USA
Alpharetta, GA 30005
USA
Phone
Website
Email Address
Overview
Biopharmaceutical company that researches, develops and commercializes prescription ophthalmic pharmaceuticals with a focus on the back of the eye, or retina.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Rick Eiswirth
Chief Financial Officer
Philip Jones
Chief Medical Officer
Samer Kaba
Chief Operating Officer
Philip Ashman
VP - Marketing
Dave Holland
Browse more venture capital transactions:
Prev: 4/21/2010: Gemin X Pharmaceuticals venture capital transaction
Next: 4/22/2010: Pluromed venture capital transaction
Share this article
Where The Data Comes From
We record all VC transactions involving tech companies. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs